Sorof J M, Vartanian R K, Olson J L, Tomlanovich S J, Vincenti F G, Amend W J
Department of Pathology, University of California San Francisco 94143, USA.
Transplantation. 1995 Dec 15;60(11):1215-9.
To assess the effect of sampling error on renal allograft biopsies, we determined the concordance of diagnoses between 2 biopsy samples from the same renal allograft and the frequency with which 1 biopsy sample would underdiagnose or lead to the undertreatment of acute rejection. Two core samples from the same allograft biopsy procedure were labeled as core A and core B and presented to both unblinded and blinded pathologists, and each pathologist independently assigned an acute and a chronic rejection grade. A set of clinical data with pertinent prebiopsy information was combined with either the core A or core B histopathological diagnosis and presented to 3 transplant nephrologists who made treatment recommendations for each combination. Two cores were obtained in 79 allograft biopsies. Core pairs differed by > or = 1 grade of acute rejection in 30% and 50% of cases for unblinded and blinded pathologist readings, respectively. Moderate or severe acute rejection would have been missed with a 1 core in 9.5% of cases, increasing to 25.6% if only biopsy pairs containing at least 1 reading of moderate or severe acute rejection are included. Therapy would have failed to be increased with a single core in 7.5% of cases, increasing to 10.5% if only pairs containing at least one recommendation of an increase in therapy are included. The use of 2 cores of renal allograft tissue provides better diagnostic information and thereby leads to appropriate increases in antirejection therapy without increasing the complication rate of the procedure.
为评估抽样误差对肾移植活检的影响,我们确定了来自同一肾移植的两份活检样本之间诊断的一致性,以及一份活检样本漏诊急性排斥反应或导致急性排斥反应治疗不足的频率。将来自同一移植肾活检操作的两份芯针活检样本分别标记为芯针A和芯针B,并提交给未设盲和设盲的病理学家,每位病理学家独立给出急性和慢性排斥反应分级。将一组包含活检前相关信息的临床数据与芯针A或芯针B的组织病理学诊断结果相结合,并提交给3位移植肾内科医生,他们针对每种组合给出治疗建议。在79例移植肾活检中获取了两份芯针样本。对于未设盲和设盲的病理学家读数,芯针样本对在30%和50%的病例中急性排斥反应分级相差≥1级。9.5%的病例中,仅一份芯针样本会漏诊中度或重度急性排斥反应,若仅纳入至少有一次中度或重度急性排斥反应读数的活检样本对,这一比例会增至25.6%。7.5%的病例中,仅一份芯针样本会导致未能增加治疗,若仅纳入至少有一次增加治疗建议的样本对,这一比例会增至10.5%。使用两份肾移植组织芯针样本可提供更好的诊断信息,从而在不增加操作并发症发生率的情况下,适当增加抗排斥治疗。